MA, B., TE, S., TK, F., & AJ, W. (2023). Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity. Frontiers in endocrinology, 14, 1205490. https://doi.org/10.3389/fendo.2023.1205490
Chicago Style (17th ed.) CitationMA, Burmeister, Smith TE, Fincher TK, and Weldon AJ. "Evidence for Proton-pump Inhibitor (PPI)-associated Dysbiosis in Metabolically Unhealthy Obesity." Frontiers in Endocrinology 14 (2023): 1205490. https://doi.org/10.3389/fendo.2023.1205490.
MLA (9th ed.) CitationMA, Burmeister, et al. "Evidence for Proton-pump Inhibitor (PPI)-associated Dysbiosis in Metabolically Unhealthy Obesity." Frontiers in Endocrinology, vol. 14, 2023, p. 1205490, https://doi.org/10.3389/fendo.2023.1205490.
Warning: These citations may not always be 100% accurate.